in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Hikal reports fall in profits
7:53 AM MST | November 6, 2012 | Deepti Ramesh
Hikal (Mumbai), an outsourcing partner to companies in the pharma, biotech, agchem, and specialty chemical industries, has recorded a 81.9% fall in net profits for its fiscal second-quarter, ended 30 September 2012, compared with the year-ago period, to 20 million Indian rupees ($370,000). Second-quarter sales increased 5.5%, to Rs1.53 billion. Hikal’s pharmaceutical business recorded a 8.5% fall in second-quarter sales, to Rs800 million. The crop protection business of the company reported a 26.7% increase in second-quarter sales, to Rs730 million...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee